These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 1833202)

  • 1. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.
    Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L
    Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
    Damle NK; Doyle LV
    Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
    Ferran C; Dautry F; Mérite S; Sheehan K; Schreiber R; Grau G; Bach JF; Chatenoud L
    J Clin Invest; 1994 May; 93(5):2189-96. PubMed ID: 8182150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
    Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
    Landis RC; Friedman ML; Fisher RI; Ellis TM
    J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation.
    Ferran C; Sheehan K; Dy M; Schreiber R; Merite S; Landais P; Noel LH; Grau G; Bluestone J; Bach JF
    Eur J Immunol; 1990 Mar; 20(3):509-15. PubMed ID: 2138557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
    Bemelmans MH; Abramowicz D; Gouma DJ; Goldman M; Buurman WA
    J Immunol; 1994 Jul; 153(2):499-506. PubMed ID: 8021491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo.
    Scott DE; Gause WC; Finkelman FD; Steinberg AD
    J Immunol; 1990 Oct; 145(7):2183-8. PubMed ID: 2144547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T lymphocyte activation induced by monoclonal anti-CD3 antibodies: physiopathology of cytokine release].
    Chatenoud L; Bach JF
    C R Seances Soc Biol Fil; 1991; 185(5):268-77. PubMed ID: 1806186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells.
    Davidson WF; Calkins C; Hügins A; Giese T; Holmes KL
    J Immunol; 1991 Jun; 146(12):4138-48. PubMed ID: 1674953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
    Alegre ML; Collins AM; Pulito VL; Brosius RA; Olson WC; Zivin RA; Knowles R; Thistlethwaite JR; Jolliffe LK; Bluestone JA
    J Immunol; 1992 Jun; 148(11):3461-8. PubMed ID: 1534096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
    Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
    Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of IL-2 production by activation of T cells through Ly-6A/E.
    Codias EK; Rutter JE; Fleming TJ; Malek TR
    J Immunol; 1990 Sep; 145(5):1407-14. PubMed ID: 2143518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nakahara memorial lecture. Regulation of T lymphocyte responses: interactions among receptors.
    Fitch F; Gajewski T; Nau G; Schell S; Otten G
    Princess Takamatsu Symp; 1988; 19():15-27. PubMed ID: 2978617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.
    Krutmann J; Kirnbauer R; Köck A; Schwarz T; Schöpf E; May LT; Sehgal PB; Luger TA
    J Immunol; 1990 Sep; 145(5):1337-42. PubMed ID: 2143517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
    Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels.
    Matthys P; Dillen C; Proost P; Heremans H; Van Damme J; Billiau A
    Eur J Immunol; 1993 Sep; 23(9):2209-16. PubMed ID: 8370401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.